MAPT and Alzheimer disease: In order to further test the overall consistency of gene expression in these biopsies, we performed differential gene expression and directly compared biopsy tissue with no AD pathology (no β-amyloid or tau, n = 32) to biopsy tissue with any AD pathology (either β-amyloid and/or tau, n = 74).